Assignee
APOTEX INC
CA·62 granted patents·23 pending applications·476 citations·filing 1993–2024
Top patents by PatentIndex Score
85 records- 0195US11377456B2Crystalline form of RemdesivirAPOTEX INC·Filed 2021·Granted Jul 5, 2022·16 cites·21 claims
- 0291US10800787B2Process for the preparation of acalabrutinibAPOTEX INC·Filed 2018·Granted Oct 13, 2020·9 cites·10 claims
- 0391US6426418B1Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamideAPOTEX INC·Filed 2001·Granted Jul 30, 2002·38 cites·5 claims
- 0486US10016423B2Solid forms of nilotinib hydrochlorideAPOTEX INC·Filed 2015·Granted Jul 10, 2018·8 cites·19 claims
- 0586US5908959AProcess for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereofAPOTEX INC·Filed 1998·Granted Jun 1, 1999·42 cites·11 claims
- 0685US5393893AProcess for producing simvastatin and analogs thereofAPOTEX INC·Filed 1993·Granted Feb 28, 1995·43 cites·17 claims
- 0784US10487059B2Crystalline form of EluxadolineAPOTEX INC·Filed 2018·Granted Nov 26, 2019·2 cites·7 claims
- 0884US10183024B2Crystalline forms of ibrutinibAPOTEX INC·Filed 2017·Granted Jan 22, 2019·2 cites·5 claims
- 0982US9376419B2Solid forms of nilotinib hydrochlorideAPOTEX INC·Filed 2013·Granted Jun 28, 2016·6 cites·18 claims
- 1082US6245903B1Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereofAPOTEX INC·Filed 1999·Granted Jun 12, 2001·66 cites·9 claims
- 1181US9944616B2Processes for the preparation of Tasimelteon and intermediates thereofAPOTEX INC·Filed 2017·Granted Apr 17, 2018·2 cites·20 claims
- 1281US9260438B2Solid forms of tofacitinib saltsAPOTEX INC·Filed 2015·Granted Feb 16, 2016·3 cites·4 claims
- 1380US11236066B2Crystalline forms of niraparib tosylateAPOTEX INC·Filed 2020·Granted Feb 1, 2022·1 cites·20 claims
- 1479US10513504B2Processes for the preparation of apalutamide and intermediates thereofAPOTEX INC·Filed 2019·Granted Dec 24, 2019·2 cites·19 claims
- 1578US11046638B2Processes for the preparation of zuclomiphene and intermediates thereofAPOTEX INC·Filed 2020·Granted Jun 29, 2021·1 cites·17 claims
- 1677US6476229B1Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamideAPOTEX INC·Filed 2002·Granted Nov 5, 2002·8 cites·3 claims
- 1776US6472532B1Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-OXO-1,4-dihydropyridine-2-carboxamideAPOTEX INC·Filed 2002·Granted Oct 29, 2002·7 cites·3 claims
- 1875US7049328B2Use for deferiproneAPOTEX INC·Filed 2001·Granted May 23, 2006·14 cites·20 claims
- 1974US6468977B1Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymesAPOTEX INC·Filed 2000·Granted Oct 22, 2002·12 cites·50 claims
- 2073US5847118AMethods for the manufacture of amorphous cefuroxime axetilAPOTEX INC·Filed 1997·Granted Dec 8, 1998·21 cites·6 claims
- 2172US9382233B2Forms of vilazodone and processes for the preparation thereofAPOTEX INC·Filed 2013·Granted Jul 5, 2016·1 cites·10 claims
- 2271US10513500B2Crystalline forms of LesinuradAPOTEX INC·Filed 2017·Granted Dec 24, 2019·1 cites·15 claims
- 2370US11814356B1Salt of cabozantinibAPOTEX INC·Filed 2023·Granted Nov 14, 2023·0 cites·16 claims
- 2470USRE39087EAzithromycin monohydrate isopropanol clathrate and methods for the manufacture thereofAPOTEX INC·Filed 2003·Granted May 2, 2006·3 cites·42 claims
- 2569US6506929B1Process to manufacture simvastatin and intermediatesAPOTEX INC·Filed 2001·Granted Jan 14, 2003·5 cites·17 claims
- 2668US10822309B2Crystalline form of EluxadolineAPOTEX INC·Filed 2019·Granted Nov 3, 2020·0 cites·9 claims
- 2767US5433256APill guide and dispenser trayAPOTEX INC·Filed 1994·Granted Jul 18, 1995·33 cites·12 claims
- 2865US5914401AMethods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereofAPOTEX INC·Filed 1998·Granted Jun 22, 1999·11 cites·16 claims
- 2965US2024409547A1Solid Forms of UpadacitinibAPOTEX INC·Filed 2024·Application pending·0 cites
- 3064US2024116884A1Salts of ViloxazineAPOTEX INC·Filed 2023·Application pending·0 cites
- 3163US10611772B2Crystalline form of Ribociclib succinateAPOTEX INC·Filed 2019·Granted Apr 7, 2020·0 cites·11 claims
- 3263US9809551B2Solid forms of Ivacaftor and processes for the preparation thereofAPOTEX INC·Filed 2014·Granted Nov 7, 2017·3 cites·9 claims
- 3363US6060472AThiadiazole compounds useful as inhibitors of H+ /K+ atpaseAPOTEX INC·Filed 1998·Granted May 9, 2000·10 cites·21 claims
- 3463US2024018090A1Processes for the Preparation of FenfluramineAPOTEX INC·Filed 2023·Application pending·0 cites
- 3562US11220500B2Crystalline form of Valbenazine dibesylateAPOTEX INC·Filed 2019·Granted Jan 11, 2022·0 cites·18 claims
- 3662US5677302AThiadiazole compounds useful as proton pump inhibitorsAPOTEX INC·Filed 1996·Granted Oct 14, 1997·19 cites·32 claims
- 3761US7410985B2Cycloalkyl derivatives of 3-hydroxy-4-pyridinonesAPOTEX INC·Filed 2004·Granted Aug 12, 2008·1 cites·15 claims
- 3861US6114537AProcess for scavenging thiolsAPOTEX INC·Filed 1997·Granted Sep 5, 2000·20 cites·5 claims
- 3961US5900485AMethods for the manufacture of neofazodoneAPOTEX INC·Filed 1997·Granted May 4, 1999·8 cites·17 claims
- 4060US11667656B2Crystalline forms of Tenofovir alafenamideAPOTEX INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 4160US11578025B2Processes for the preparation of zuclomiphene intermediatesAPOTEX INC·Filed 2021·Granted Feb 14, 2023·0 cites·16 claims
- 4260US2025049774A1Crystalline Forms of ApalutamideAPOTEX INC·Filed 2022·Application pending·0 cites
- 4359US10662178B2Crystalline form of OlaparibAPOTEX INC·Filed 2019·Granted May 26, 2020·0 cites·14 claims
- 4459US10407396B2Crystalline form of selexipagAPOTEX INC·Filed 2018·Granted Sep 10, 2019·0 cites·19 claims
- 4559US2025019346A1Salts of Ruxolitinib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 4658US10556887B2Processes for the preparation of Veliparib and intermediates thereofAPOTEX INC·Filed 2018·Granted Feb 11, 2020·0 cites·20 claims
- 4758US5723618A1,4-dihydropyridines, N-substituted bicyclic 4-hydropyridines, and bicyclic N-substituted 4,5-dihydropyridinesAPOTEX INC·Filed 1996·Granted Mar 3, 1998·7 cites·12 claims
- 4857US10066001B2Enhanced liquid formulation stability of erythropoietin alpha through purification processingAPOTEX INC·Filed 2014·Granted Sep 4, 2018·0 cites·11 claims
- 4957US6024247ADeblistering machineAPOTEX INC·Filed 1997·Granted Feb 15, 2000·25 cites·4 claims
- 5055US11980622B1Oxcarbazepine extended release dosage formAPOTEX INC·Filed 2022·Granted May 14, 2024·0 cites·23 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when APOTEX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →